• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

埃及结直肠癌患者结肠切除术后粪便样本的宏基因组分析:一项初步研究。

Metagenomic analysis of fecal samples in colorectal cancer Egyptians patients post colectomy: A pilot study.

作者信息

Abo-Hammam Rana H, Salah Mohammed, Shabayek Sarah, Hanora Amro, Zakeer Samira, Khattab Randa H

机构信息

Forensic toxicologist and narcotics expert, Ministry of Justice, Tanta, Egypt.

Department of Microbiology and Immunology, Faculty of pharmacy, Port-Said University, Port-Said, Egypt.

出版信息

AIMS Microbiol. 2024 Feb 20;10(1):148-160. doi: 10.3934/microbiol.2024008. eCollection 2024.

DOI:10.3934/microbiol.2024008
PMID:38525041
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10955169/
Abstract

One of the most prevalent malignancies that significantly affects world health is colorectal cancer (CRC). While genetics are involved in a portion of CRC patients, most cases are sporadic. The microbiome composition could be a new source of tumor initiation and progression. This research was conducted to investigate the microbiota composition of CRC patients post colectomy at taxonomic and functional levels. Using a next-generation sequencing approach, using an Illumina Novaseq 6000, the fecal samples of 13 patients were analyzed and the obtained data was subjected to a bioinformatics analysis. The bacterial abundance and uniqueness varied in CRC patients alongside differences in bacterial counts between patients. , , , and were among the pro-cancerous microorganisms found. Concurrently, bacteria linked to CRC progression were detected that have been previously linked to metastasis and recurrence. At the same time, probiotic bacteria such as , , and increased in abundance after colectomies. Additionally, numerous pathways were deferentially enriched in CRC, which emerged from functional pathways based on bacterial shotgun data. CRC-specific microbiome signatures include an altered bacterial composition. Our research showed that microbial biomarkers could be more usefully employed to explore the link between gut microbiota and CRC using metagenomic techniques in the diagnosis, prognosis, and remission of CRC, thereby opening new avenues for CRC treatment.

摘要

结直肠癌(CRC)是严重影响全球健康的最常见恶性肿瘤之一。虽然一部分CRC患者与遗传因素有关,但大多数病例是散发性的。微生物群组成可能是肿瘤发生和进展的新来源。本研究旨在从分类学和功能水平调查CRC患者结肠切除术后的微生物群组成。采用下一代测序方法,使用Illumina Novaseq 6000对13例患者的粪便样本进行分析,并对获得的数据进行生物信息学分析。CRC患者的细菌丰度和独特性各不相同,患者之间的细菌计数也存在差异。在发现的促癌微生物中,有[具体微生物名称1]、[具体微生物名称2]、[具体微生物名称3]和[具体微生物名称4]。同时,检测到与CRC进展相关的细菌,这些细菌先前已与转移和复发相关联。与此同时,诸如[具体益生菌名称1]、[具体益生菌名称2]和[具体益生菌名称3]等益生菌在结肠切除术后丰度增加。此外,基于细菌鸟枪法数据的功能途径中出现了许多在CRC中差异富集的途径。CRC特异性微生物群特征包括细菌组成的改变。我们的研究表明,微生物生物标志物可更有效地用于利用宏基因组技术探索肠道微生物群与CRC在诊断、预后和缓解方面的联系,从而为CRC治疗开辟新途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d14/10955169/8929a2c18fa5/microbiol-10-01-008-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d14/10955169/b39407742792/microbiol-10-01-008-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d14/10955169/7f0705258a9a/microbiol-10-01-008-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d14/10955169/9eeb8ed353ab/microbiol-10-01-008-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d14/10955169/8929a2c18fa5/microbiol-10-01-008-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d14/10955169/b39407742792/microbiol-10-01-008-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d14/10955169/7f0705258a9a/microbiol-10-01-008-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d14/10955169/9eeb8ed353ab/microbiol-10-01-008-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d14/10955169/8929a2c18fa5/microbiol-10-01-008-g004.jpg

相似文献

1
Metagenomic analysis of fecal samples in colorectal cancer Egyptians patients post colectomy: A pilot study.埃及结直肠癌患者结肠切除术后粪便样本的宏基因组分析:一项初步研究。
AIMS Microbiol. 2024 Feb 20;10(1):148-160. doi: 10.3934/microbiol.2024008. eCollection 2024.
2
Diet-mediated gut microbial community modulation and signature metabolites as potential biomarkers for early diagnosis, prognosis, prevention and stage-specific treatment of colorectal cancer.饮食介导的肠道微生物群落调节和特征代谢产物作为结直肠癌早期诊断、预后、预防和分期特异性治疗的潜在生物标志物。
J Adv Res. 2023 Oct;52:45-57. doi: 10.1016/j.jare.2022.12.015. Epub 2022 Dec 31.
3
Disease-associated gut microbiome and critical metabolomic alterations in patients with colorectal cancer.结直肠癌患者相关肠道微生物组和关键代谢组学的改变。
Cancer Med. 2023 Jul;12(14):15720-15735. doi: 10.1002/cam4.6194. Epub 2023 Jun 1.
4
Association between colorectal cancer and Fusobacterium nucleatum and Bacteroides fragilis bacteria in Iranian patients: a preliminary study.伊朗患者中结直肠癌与具核梭杆菌和脆弱拟杆菌之间的关联:一项初步研究。
Infect Agent Cancer. 2021 Jun 9;16(1):41. doi: 10.1186/s13027-021-00381-4.
5
Microbial dynamics with CRC progression: a study of the mucosal microbiota at multiple sites in cancers, adenomatous polyps, and healthy controls.CRC 进展中的微生物动态:在癌症、腺瘤性息肉和健康对照的多个部位的黏膜微生物组中进行的研究。
Eur J Clin Microbiol Infect Dis. 2023 Mar;42(3):305-322. doi: 10.1007/s10096-023-04551-7. Epub 2023 Jan 27.
6
Gut Microbiota in Colorectal Cancer: Biological Role and Therapeutic Opportunities.结直肠癌中的肠道微生物群:生物学作用与治疗机遇
Cancers (Basel). 2023 Jan 30;15(3):866. doi: 10.3390/cancers15030866.
7
Aging characteristics of colorectal cancer based on gut microbiota.基于肠道微生物组的结直肠癌衰老特征。
Cancer Med. 2023 Sep;12(17):17822-17834. doi: 10.1002/cam4.6414. Epub 2023 Aug 7.
8
Exploring the Role of Gut Microbiome in Colon Cancer.探讨肠道微生物组在结肠癌中的作用。
Appl Biochem Biotechnol. 2021 Jun;193(6):1780-1799. doi: 10.1007/s12010-021-03498-9. Epub 2021 Jan 25.
9
Altered gut microbiome composition by appendectomy contributes to colorectal cancer.阑尾切除术改变的肠道微生物组成与结直肠癌有关。
Oncogene. 2023 Feb;42(7):530-540. doi: 10.1038/s41388-022-02569-3. Epub 2022 Dec 20.
10
Parvimonas micra, Peptostreptococcus stomatis, Fusobacterium nucleatum and Akkermansia muciniphila as a four-bacteria biomarker panel of colorectal cancer.微小消化链球菌、口腔普氏菌、具核梭杆菌和黏蛋白阿克曼菌作为结直肠癌的四重细菌生物标志物组合。
Sci Rep. 2021 Feb 3;11(1):2925. doi: 10.1038/s41598-021-82465-0.

引用本文的文献

1
Advances in gut microbiota-related treatment strategies for managing colorectal cancer in humans.人类结直肠癌肠道微生物群相关治疗策略的进展
Cancer Biol Med. 2025 Mar 12;22(2):93-112. doi: 10.20892/j.issn.2095-3941.2024.0263.
2
Long-read 16S rRNA amplicon sequencing reveals microbial characteristics in patients with colorectal adenomas and carcinoma lesions in Egypt.长读长16S rRNA扩增子测序揭示埃及结直肠腺瘤和癌性病变患者的微生物特征。
Gut Pathog. 2025 Feb 2;17(1):8. doi: 10.1186/s13099-025-00681-9.
3
Colorectal cancer-specific microbiome in peripheral circulation and cancer tissues.

本文引用的文献

1
Potential effects of gut microbiota on host cancers: focus on immunity, DNA damage, cellular pathways, and anticancer therapy.肠道微生物群对宿主癌症的潜在影响:关注免疫、DNA 损伤、细胞途径和抗癌治疗。
ISME J. 2023 Oct;17(10):1535-1551. doi: 10.1038/s41396-023-01483-0. Epub 2023 Aug 8.
2
Correction: Porphyromonas Gingivalis Promotes Colorectal Carcinoma by Activating the Hematopoietic NLRP3 Inflammasome.更正:牙龈卟啉单胞菌通过激活造血NLRP3炎性小体促进结直肠癌。
Cancer Res. 2022 Jun 6;82(11):2196. doi: 10.1158/0008-5472.CAN-22-1136.
3
Faecal microbial biomarkers in early diagnosis of colorectal cancer.
外周循环和癌组织中结直肠癌特异性微生物群
Front Microbiol. 2024 Aug 21;15:1422536. doi: 10.3389/fmicb.2024.1422536. eCollection 2024.
粪便微生物生物标志物在结直肠癌早期诊断中的应用。
J Cell Mol Med. 2021 Dec;25(23):10783-10797. doi: 10.1111/jcmm.17010. Epub 2021 Nov 9.
4
Potentiates the Antitumor Efficacy of FOLFOX in Colon Cancer.增强FOLFOX方案对结肠癌的抗肿瘤疗效。
Front Pharmacol. 2021 Sep 17;12:725583. doi: 10.3389/fphar.2021.725583. eCollection 2021.
5
Targeting Pyrimidine Metabolism in the Era of Precision Cancer Medicine.精准癌症医学时代的嘧啶代谢靶向治疗
Front Oncol. 2021 May 28;11:684961. doi: 10.3389/fonc.2021.684961. eCollection 2021.
6
Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3.利用 bioBakery 3 整合具有分类学、功能和菌株水平特征的多样化微生物群落。
Elife. 2021 May 4;10:e65088. doi: 10.7554/eLife.65088.
7
Metagenome Analysis of Intestinal Bacteria in Healthy People, Patients With Inflammatory Bowel Disease and Colorectal Cancer.健康人群、炎症性肠病和结直肠癌患者肠道细菌的宏基因组分析。
Front Cell Infect Microbiol. 2021 Feb 26;11:599734. doi: 10.3389/fcimb.2021.599734. eCollection 2021.
8
Gut Microbiota-Mediated Inflammation and Gut Permeability in Patients with Obesity and Colorectal Cancer.肠道微生物群介导的肥胖和结直肠癌患者的炎症和肠道通透性。
Int J Mol Sci. 2020 Sep 16;21(18):6782. doi: 10.3390/ijms21186782.
9
Current challenges and best-practice protocols for microbiome analysis.当前微生物组分析面临的挑战和最佳实践方案。
Brief Bioinform. 2021 Jan 18;22(1):178-193. doi: 10.1093/bib/bbz155.
10
Association of Flavonifractor plautii, a Flavonoid-Degrading Bacterium, with the Gut Microbiome of Colorectal Cancer Patients in India.印度结直肠癌患者肠道微生物群与黄酮类降解菌普拉蒂黄酮分解菌的关联。
mSystems. 2019 Nov 12;4(6):e00438-19. doi: 10.1128/mSystems.00438-19.